Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer
Sarah A. Best, Patrick M. Gubser, Shalini Sethumadhavan, et al.
Cell Metabolism (2022) Vol. 34, Iss. 6, pp. 874-887.e6
Open Access | Times Cited: 97

Showing 26-50 of 97 citing articles:

Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Pancreatic stellate cells exploit Wnt/β-catenin/TCF7-mediated glutamine metabolism to promote pancreatic cancer cells growth
Hangqi Liu, Hui Zhang, Xiaoqian Liu, et al.
Cancer Letters (2022) Vol. 555, pp. 216040-216040
Closed Access | Times Cited: 27
Neurotransmitters: promising immune modulators in the tumor microenvironment
Luxi Xiao, Xunjun Li, Chuanfa Fang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Tumor microenvironmental nutrients, cellular responses, and cancer
Graham P. Lobel, Yanqing Jiang, M. Celeste Simon
Cell chemical biology (2023) Vol. 30, Iss. 9, pp. 1015-1032
Open Access | Times Cited: 13
Predictive role of SLC1A5 in neuroblastoma prognosis and immunotherapy
Jian Cheng, Miaomiao Sun, Dong Xiao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Metabolic Singularities in Microsatellite-Stable Colorectal Cancer: Identifying Key Players in Immunosuppression to Improve the Immunotherapy Response
Teresa Gorría, Marina Sierra-Boada, Mariam Rojas, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 498-498
Open Access
Multi-omics analysis reveals the sensitivity of immunotherapy for unresectable non-small cell lung cancer
Rui Wu, K. Wei, Xingshuai Huang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Cuproptosis amplifier of copper-telaglenastat coordinate to trigger cell ferroptosis for synergistic breast cancer suppression
Linping Zhao, Jianqiao Li, Guangmiao Chen, et al.
Chinese Chemical Letters (2025), pp. 110959-110959
Closed Access
Current efficacy of immune checkpoint inhibitors in microsatellite unstable colorectal cancer and potential biomarkers
Mariam Rojas, Clara Ugueto Rodrigo, Reinaldo Moreno, et al.
(2025) Vol. 4
Open Access
Metformin combined with CB-839 specifically inhibits KRAS-mutant ovarian cancer
Han Wu, Jialin Zhang, Qiujie Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Reprogramming Glutamine Metabolism of Dendritic Cells Boosts Lymph Nodes Migration and Tumor Immunotherapy
Yi Pan, Lulu Jin, Yang Huang, et al.
Advanced Functional Materials (2025)
Closed Access
Integration of multiple machine learning approaches develops a gene mutation-based classifier for accurate immunotherapy outcomes
Run Shi, Jing Sun, Zhaokai Zhou, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
Jingyang Li, Xiang Li, Shaohui Wang, et al.
Deleted Journal (2025)
Open Access
Health position paper and redox perspectives – Bench to Bedside Transition for Pharmacological Regulation of NRF2 in Noncommunicable Diseases
Antonio Cuadrado, Eduardo Cazalla, Anders Bach, et al.
Redox Biology (2025), pp. 103569-103569
Open Access
Methionine Metabolism Dictates PCSK9 Expression and Antitumor Potency of PD‐1 Blockade in MSS Colorectal Cancer
Qi‐Long Wang, Zijie Chen, Xiaofei Lü, et al.
Advanced Science (2025)
Open Access
Liver kinase B1 expression is associated with improved prognosis and tumor immune microenvironment features in small cell lung cancer
Alessandro Dal Maso, Federica Ferrarini, Giovanni Esposito, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Computational modeling of metabolism in oncology
Linda Fong, Meng Jin, Samir Kharbanda, et al.
Elsevier eBooks (2025), pp. 81-107
Closed Access
Amino acids in cancer: Understanding metabolic plasticity and divergence for better therapeutic approaches
K. Linda, Hyun Min Lee, Yun‐Sok Ha, et al.
Cell Reports (2025) Vol. 44, Iss. 4, pp. 115529-115529
Open Access
Glutamine’s double-edged sword: fueling tumor growth and offering therapeutic hope
Liguang Fang, Dandan Gao, Zhe Jiang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Age- and diet-instructed metabolic rewiring of the tumor–immune microenvironment
Ana Belén Plata-Gómez, Ping‐Chih Ho
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 6
Closed Access
Targeting T-cell metabolism to boost immune checkpoint inhibitor therapy
Haohao Li, Alison Zhao, Meng-Hua Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T Cells
Matthew Z. Madden, Xiang Ye, Channing Chi, et al.
The Journal of Immunology (2023) Vol. 211, Iss. 4, pp. 563-575
Open Access | Times Cited: 12
Enhancing personalized immune checkpoint therapy by immune archetyping and pharmacological targeting
Claudia Cerella, Mario Dicato, Marc Diederich
Pharmacological Research (2023) Vol. 196, pp. 106914-106914
Open Access | Times Cited: 12
Xanthine dehydrogenase rewires metabolism and the survival of nutrient deprived lung adenocarcinoma cells by facilitating UPR and autophagic degradation
Man Chen, Wei Guo, Si-meng Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 3, pp. 772-788
Open Access | Times Cited: 11
Crosstalk between arginine, glutamine, and the branched chain amino acid metabolism in the tumor microenvironment
Tanner J. Wetzel, Sheila C. Erfan, Lucas Figueroa, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11

Scroll to top